Non-Alcoholic Fatty Liver Disease Modifies Serum Gamma-Glutamyl Transferase in Cigarette Smokers
Oni ET, Figueredo V, Aneni E, Veladar E, McEvoy JW, Blaha MJ, Blumenthal RS, Conceicao RD, Carvalho JAM, Santos RD, Nasir K. Non-Alcoholic Fatty Liver Disease Modifies Serum Gamma-Glutamyl Transferase in Cigarette Smokers. Journal Of Clinical Medicine Research 2020, 12: 472-482. PMID: 32849935, PMCID: PMC7430878, DOI: 10.14740/jocmr3932.Peer-Reviewed Original ResearchNon-alcoholic fatty liver diseaseGamma-glutamyl transferaseSerum gamma-glutamyl transferaseClinical cardiovascular diseaseHigh GGT levelsGGT levelsNAFLD statusOxidative stressAbsence of NAFLDPresence of NAFLDPrevalence of NAFLDFatty liver diseaseImpact of smokingCross-sectional associationsCV riskCardiovascular riskCurrent smokersCurrent smokingMultivariable adjustmentLiver diseaseCigarette smokersEffect modificationCardiovascular diseaseHealthy subjectsSmoking